{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18360", "batch_size": 260, "batch_pos": 57, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The language used is neutral and factual.", "method": "llm_batch", "batch_id": "batch_2_17896", "batch_size": 260, "batch_pos": 21, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment is about discussions and advancing candidates, not virus impact via moderate verb + scale.", "method": "llm_batch", "batch_id": "batch_3_6040", "batch_size": 260, "batch_pos": 212, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14784", "batch_size": 260, "batch_pos": 185, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions with government, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15088", "batch_size": 260, "batch_pos": 182, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment expresses confirmation ('can confirm we are in discussions') which is confidence/preparedness, not minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17476", "batch_size": 260, "batch_pos": 144, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment reports confirming discussions, containing no negation.", "method": "llm_batch", "batch_id": "batch_7_15756", "batch_size": 260, "batch_pos": 124, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes ongoing work towards a future capability: 'confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate'.", "method": "llm_batch", "batch_id": "batch_8_17656", "batch_size": 260, "batch_pos": 220, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
